Clinical activity of the ALK inhibitor LDK378 in advanced, ALK-positive NSCLC.
Alice Tsang Shaw
Consultant or Advisory Role - ARIAD; Chugai Pharma; Novartis; Pfizer
Ranee Mehra
No relevant relationships to disclose
Dong-Wan Kim
Consultant or Advisory Role - Novartis
Enriqueta Felip
Consultant or Advisory Role - Boehringer Ingelheim; Lilly; Roche
Laura Quan Man Chow
Research Funding - Novartis
D. Ross Camidge
Consultant or Advisory Role - Novartis
Daniel Shao-Weng Tan
Research Funding - Novartis
Johan F. Vansteenkiste
No relevant relationships to disclose
Sunil Sharma
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Tommaso De Pas
No relevant relationships to disclose
Juergen Wolf
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Ryohei Katayama
No relevant relationships to disclose
Yi-Yang Yvonne Lau
Employment or Leadership Position - Novartis
Meredith Goldwasser
Employment or Leadership Position - Novartis
Anthony Boral
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Jeffrey A. Engelman
Consultant or Advisory Role - Novartis
Research Funding - Novartis